ticagrelor


Also found in: Medical, Wikipedia.
Related to ticagrelor: Prasugrel
Translations

ticagrelor

n ticagrelor m
References in periodicals archive ?
During the current admission, a loading dose of aspirin (300 mg) and ticagrelor (180 mg) was given and primary PCI was immediately performed.
And clinicians who started patients on ticagrelor did not usually switch those with a good clopidogrel-metabolizing profile to the safer drug, clopidogrel, after learning that clopidogrel would be fully effective.
Medications commonly given after placement of a stent include Clopidogrel (Plavix), ticagrelor (Brilinta), prasugrel (Effient), and aspirin.
Limited Tenders are invited for Supply of Ticagrelor 90Mg Tab Qty: 9600 nos.
The comprehensive new version reflects current best practices for using aspirin combined with P2Y12 receptor inhibitors clopidogrel, prasugrel or ticagrelor, and includes a review of 11 studies of patients treated with coronary stent implantation done predominately with drug-eluting stents to assess the risks and benefits of shorter-versus longer-duration dual antiplatelet therapy.
But ticagrelor (Brilinta) had no effect at all in those without stenosis (HR, 0.
gov identifier: NCT00391872) randomized 18624 patients with ST-elevation and non-ST-elevation acute coronary syndromes to ticagrelor or clopidogrel for the prevention of cardiovascular events.
However, prasugrel and ticagrelor should not be used in such patients because the use of these agents has not been studied yet as an adjunctive treatment in fibrinolysis (2, 4).
Either ticagrelor (Brilinta) at 90 mg twice daily or prasugrel (Effient) once daily at 10 mg is recommended over clopidogrel at 75 mg/day in patients who can take those medications safely; this guidance is based on ticagrelor's superior efficacy compared with clopidogrel as shown in TRITON TIMI-38 (N.
CHICAGO -- The benefit from dual-anti-platelet therapy in high-risk patients following a myocardial infarction was especially apparent in post-MI patients with diabetes in a prespecified secondary analysis from a multicenter trial of ticagrelor with more than 21,000 patients.
Due to financial constraints, ticagrelor or prasugrel could not be prescribed.
The medication regimen designed to block stent thrombosis is called dual antiplatelet therapy (DAPT), and it consists of aspirin and an antiplatelet drug such as clopidogrel (Plavix), prasugrel (Effient), or ticagrelor (Brilinta).